Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EMG | Ann: EMG NTA 29-07-2025 $2.91197 | 08:02 | 0 | 30 | |||
|
|||||||
EMG | Ann: EMG NTA 28-07-2025 $2.90928 | 29/07/25 | 0 | 56 | |||
|
|||||||
EMG | Ann: EMG NTA 25-07-2025 $2.90927 | 28/07/25 | 0 | 47 | |||
|
|||||||
EMG | Ann: EMG NTA 24-07-2025 $2.91722 | 25/07/25 | 0 | 44 | |||
|
|||||||
EMG | Ann: EMG NTA 23-07-2025 $2.91319 | 24/07/25 | 0 | 54 | |||
|
|||||||
EMG | Ann: EMG NTA 22-07-2025 $2.93912 | 23/07/25 | 0 | 56 | |||
|
|||||||
EMG | Ann: EMG NTA 21-07-2025 $2.92417 | 22/07/25 | 0 | 59 | |||
|
|||||||
EMG | Ann: EMG NTA 18-07-2025 $2.94134 | 21/07/25 | 0 | 74 | |||
|
See All Discussions